Pluri Inc.

Regulatory Filings • Sep 23, 2008

8-K 1 zk85832.htm Created by EDGAR Ease Plus (EDGAR Ease+) Project: F:\EDGAR Filing\Pluristem Therapeutics Inc\85832\a85832.eep Control Number: 85832 Rev Number: 1 Client Name: Pluristem Therapeutics Inc Project Name: 8-K Firm Name: Zadok-Keinan Ltd 8-K MARKER FORMAT-SHEET="Top Scotch Rule Top-TNR" FSL="Workstation" MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation"

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549

MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation"

Form 8-K

MARKER FORMAT-SHEET="Head Major Center Bold 1-TNR" FSL="Workstation"

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): September 23, 2008 (September 22, 2008)

MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation"

PLURISTEM THERAPEUTICS INC. (Exact name of registrant as specified in its charter)

Nevada	001-31392	98-0351734
(State or other jurisdiction of incorporation)	(Commission file number)	(I.R.S. Employer Identification Number)

MATAM Advanced Technology Park
Building No. 20
Haifa, Israel	31905
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code: 011 972 74 710 7171

n/a (Former name or former address, if changed since last report)

MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Workstation"

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

MARKER FORMAT-SHEET="Para Hang Lv 1-TNR" FSL="Workstation"

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

MARKER FORMAT-SHEET="Para Hang Lv 1-TNR" FSL="Workstation"

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

MARKER FORMAT-SHEET="Para Hang Lv 1-TNR" FSL="Workstation"

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

MARKER FORMAT-SHEET="Para Hang Lv 1-TNR" FSL="Workstation"

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

MARKER FORMAT-SHEET="Exhibit Index Hang" FSL="Workstation"

Item 1.01 Entry into a Material Definitive Agreement

MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Workstation"

On September 22, 2008, we sold 900,000 shares of our common stock (“Common Stock”) and warrants (“Warrants”) to purchase 675,000 shares of Common Stock to an investor pursuant to terms of a securities purchase agreement. The price per share of Common Stock is $1.15, and the exercise price of the Warrants is $1.90. The Warrants will be exercisable for a period of five years.

MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Workstation"

A copy of the form of Warrant is attached as Exhibit 4.1 to this report and is incorporated herein by reference. The description of the Warrants is a summary only and is qualified in its entirety by reference to Exhibit 4.1. A copy of the form of securities purchase agreement is attached as Exhibit 10.1 to this report and is incorporated herein by reference.

MARKER FORMAT-SHEET="Para Large Indent Lv 0-TNR" FSL="Workstation"

The offering was made pursuant to our shelf registration statement on Form S-3 (File No. 333-151761). We are filing with the SEC, pursuant to Rule 424(b) under the Securities Act of 1933, as amended, a prospectus supplement related to the offering.

MARKER FORMAT-SHEET="Exhibit Index Hang" FSL="Workstation"

Item 9.01 Statements and Exhibits

MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation"

(d) Exhibits:

MARKER FORMAT-SHEET="Exhibit Index Hang" FSL="Workstation"

4.1 Form of Common Stock Purchase Warrant dated September 22, 2008

MARKER FORMAT-SHEET="Exhibit Index Hang" FSL="Workstation"

5.1 Opinion of Zysman, Aharoni, Gayer & Co./ Sullivan & Worcester LLP

MARKER FORMAT-SHEET="Exhibit Index Hang" FSL="Workstation"

10.1 Form of Securities Purchase Agreement dated September 22, 2008

MARKER FORMAT-SHEET="Exhibit Index Hang" FSL="Workstation"

23.1 Consent of Zysman, Aharoni, Gayer & Co./ Sullivan & Worcester LLP (included in Exhibit 5.1).

MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation"

SIGNATURES

MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Workstation"

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MARKER FORMAT-SHEET="Signature (Single)" FSL="Workstation"

Date: September 23, 2008 PLURISTEM THERAPEUTICS INC. By: /s/ Yaky Yanay —————————————— Yaky Yanay Chief Financial Officer